ALNYLAM PHARMACEUT earnings per share and revenue

DUL earnings per share for the last quarter are -0.47 CHF whereas the estimation was -1.01 CHF which accounts for 53.41% surprise. Company revenue for the same period amounts to 445.95 M CHF despite the estimated figure of 386.11 M CHF. Estimated earnings per share for the next quarter are -0.96 CHF, and revenue is expected to reach 406.41 M CHF. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.